Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Biobased chemicals firm Amyris is launching a drug discovery and production business based on its technology for designing microbes for biochemical synthesis. Amyris says the business is an outgrowth of its successful production of the malaria drug precursor artemisinic acid and its experience scaling up biobased chemicals. Customers will receive gene-editing tools, high-throughput screening technology, and industrial-scale fermentation infrastructure. The company says its processes are ideal for making compounds for which a natural source is scarce or chemical synthesis is not cost-effective.
This article has been sent to the following recipient: